|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Chiara RambaldiPublisher: Springer Nature Switzerland AG Imprint: Palgrave Macmillan ISBN: 9783032264527ISBN 10: 3032264529 Pages: 305 Publication Date: 31 July 2026 Audience: Professional and scholarly , College/higher education , Professional & Vocational , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1 Introduction – Rethinking Global Drug Policy Through SDG 3.- 2 The Origins of International Drug Control: Pre-1909 Foundations.- 3 The Birth of the International Drug Control System: 1909–1924.- 4 From Control to Codification: The Geneva Treaties and Institutionalisation (1925–1936).- 5 World War II and the Post-War Order: Fragmentation and Realignment (1936–1945).- 6 The Rise of the United Nations: The 1961 Single Convention and Beyond.- 7 The 1970s: Medical Marginalisation and the Expansion of Control.- 8 The 1980s: Security, Cartels, and the Neglect of Palliative Access.- 9 The UNGASS Decades (1990s–2008): Civil Society, Fragmentation, and the Fight for Health Justice.- 10 Conclusion: Reclaiming Health Within the Global Drug Control Regime.ReviewsAuthor InformationChiara Rambaldi is a researcher at the University of Sheffield, UK, specialising in global health policy, palliative care, and access to essential medicines. Her research focuses on the barriers to equitable access to controlled medicines for pain relief and palliative care, with particular attention to the role of international drug control policies in shaping healthcare outcomes. Drawing on health policy, post-colonial theory, and international governance, her work examines how global regulatory frameworks influence access to essential medicines across different regions of the world. She has conducted extensive archival research on the history and evolution of international drug control treaties and has contributed to academic and policy discussions on palliative care, health equity, and access to medicines. Tab Content 6Author Website:Countries AvailableAll regions |
||||